ATZUMI
DIHYDROERGOTAMINE MESYLATE
- Strength
- 5.2 mg/1
- Form
- Powder
- Class
- Ergotamine Derivative
Satsuma Pharmaceuticals, Inc.
Not stocked by us — reference only
Listed by Hikma Pharmaceuticals USA Inc.
| Dosage form | Injection |
|---|---|
| Route | Intramuscular, Intravenous, Subcutaneous |
| Drug class | Ergotamine Derivative |
| Approval route | ANDA — approved generic |
| NDC code | 0143-9151 |
| FDA application | ANDA040453 |
| RxNorm concept | 861672 |
| Package sizes listed | 1 |
| Marketed since | March 2023 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
DIHYDROERGOTAMINE MESYLATE
Satsuma Pharmaceuticals, Inc.
Not stocked by us — reference only
Dihydroergotamine Mesylate
Amneal Pharmaceuticals LLC
Not stocked by us — reference only
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
Somerset Therapeutics, LLC
Not stocked by us — reference only
Advagen Pharma Ltd
Not stocked by us — reference only
Provepharm Inc.
Not stocked by us — reference only
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
Oceanside Pharmaceuticals
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.